Outlook Therapeutics, Inc. · NASDAQ:OTLK
Kenyon Lawrence A bought 101,010 Outlook Therapeutics, Inc. shares (Form 4)
Traded Aug 14, 2026 · Filed Aug 14, 2026
On Aug 14, 2026, Kenyon Lawrence A (Director, Chief Financial Officer) bought 101,010 Outlook Therapeutics, Inc. shares, leaving 106,956 shares. Filed Aug 14, 2026 (Form 4).
- Bought
- 101,010 shares
- Holding after
- 106,956 shares
- Trading plan
- No
- Role
- Director, Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Common Stock | Buy | 101,010 | 106,956 | Direct |
Source
Related
- Outlook Therapeutics, Inc.
- Kenyon Lawrence A
- Outlook Therapeutics, Inc. shareholders
- Schedule 13G · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026
- Schedule 13D/A · GMS Ventures & Investments · Aug 14, 2026